ACA Woes Continue For Some
Glitches in the website could prevent individuals from submitting immigration documents, resulting in fines or loss of coverage.
Cabozantinib Fails in Phase 3
The company developing the drug, Excelis, now plans to focus it's attention on the ongoing kidney and liver cancer trials for the drug.
In Healthcare Reform, Helping Patients Pick the Right Doctor Is Key to Accountable Care
Of the many elements in healthcare reform, one essential has been overlooked: helping patients pick the doctor who is right for them. In an commentary appearing in Evidence-Based Oncology, a publication of The American Journal of Managed Care, Brian W. Powers and Sachin H. Jain, MD, MBA, outline a framework for accountable physician selection, noting that the higher the stakes, the more important this process.
AJMC Series Finds Positive Spin-offs for Cancer Care From New Jersey’s Higher Education Overhaul
Status in the States, the series in The American Journal of Managed Care’s news publication, Evidence-Based Oncology, took a look at cancer care in New Jersey two years after a high-profile reorganization of the state’s higher education system. The overhaul has improved collaboration within research units and with nearby pharmaceutical giants, and a new medical school reports a bumper crop of applicants.
CMS Finalizes EHR Meaningful-Use Rule, Adds Some Flexibility
The CMS late Friday finalized a rule allowing hospitals and eligible professionals more flexibility in how they meet meaningful-use requirements for the electronic health-record incentive program. The agency had first proposed the idea in a May draft rule.